|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0105 USD | -0.94% |
|
-0.94% | -52.27% |
| Feb. 22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
| 2023 | Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Baudax Bio, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 0.422 million compared to USD 0.198 million a year ago. Net loss was USD 12.81 million compared to USD 16.91 million a year ago.
Basic loss per share from continuing operations was USD 126.8 compared to USD 378.4 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -52.27% | 551K | |
| +4.09% | 43.84B | |
| +46.90% | 41.25B | |
| +9.45% | 41.68B | |
| -10.92% | 27.04B | |
| +9.32% | 25.53B | |
| -24.87% | 18.18B | |
| +29.70% | 12.29B | |
| +1.28% | 12.29B | |
| +7.78% | 11.15B |
BAUDAX BIO, INC. 
